Immunohistochemistry demonstrated the tumor cells to be positive for CD34, CD99, STAT6, and BCL-2 (Figure 4), while negative for S-100, CD45, P-CK, CD56 (focally positive), Sy, GFAP, SALL4, OCT3/4, and Desmin. The gene discussed is STAT6; the disease is neoplasm.